New Agents for Taxol-Resistant Ovarian Carcinoma

doi 10.21236/ada424595
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Synergistic Interaction Between Cisplatin and Taxol in Human Ovarian Carcinoma Cells in Vitro

British Journal of Cancer
Cancer ResearchOncology
1994English

Taxol-Resistant Epithelial Ovarian Tumors Are Associated With Altered Expression of Specific Beta-Tubulin Isotypes.

Journal of Clinical Investigation
Medicine
1997English

Leptin Contributes to the Taxol Chemoresistance in Epithelial Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2019English

New Agents on the Horizon in Hepatocellular Carcinoma

Therapeutic Advances in Medical Oncology
Oncology
2012English

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Pegylated Liposomal Doxorubicin for Platinum-Resistant or Refractory M�llerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube and Peritoneal Carcinoma): A Single-Institutional Experience

Oncology Letters
Cancer ResearchOncology
2012English

High‐Dose Therapy for Ovarian Carcinoma

Oncologist
Cancer ResearchMedicineOncology
1997English

Transcriptome-Based Signature Predicts the Effect of Taxol in Serous Ovarian Cancer

PLoS ONE
Multidisciplinary
2018English

Induction Chemotherapy With Carboplatin and Taxol Followed by Radiotherapy and Concurrent Weekly Carboplatin + Taxol in Locally Advanced Nasopharyngeal Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy